Evidence map›Paper›PMID 39326919›Full record

ArticleThe European respiratory journal2024

Inflammatory plasma protein levels are elevated years before sarcoidosis diagnosis: a nested case-control study in Sweden.

Elizabeth V Arkema, Michael C Sachs, Annica Dominicus, Anders Eklund, Anna Smed-Sörensen, Johan Grunewald, Anders Blomberg

Abstract read
In one paragraph

Article in The European respiratory journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Elizabeth V ArkemaKarolinska Institutet, Department of Medicine Solna, Clinical Epidemiology Division, Stockholm, Sweden elizabeth.arkema@ki.se.ORCID https://orcid.org/0000-0002-3677-9736
Michael C SachsKarolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-1279-8676
Annica DominicusKarolinska Institutet, Department of Medicine Solna, Clinical Epidemiology Division, Stockholm, Sweden.
Anders EklundKarolinska Institutet, Department of Medicine Solna, Respiratory Medicine Division, Stockholm, Sweden.
Anna Smed-SörensenKarolinska Institutet, Department of Medicine Solna, Division of Immunology and Allergy, Stockholm, Sweden.
Johan GrunewaldKarolinska Institutet, Department of Medicine Solna, Respiratory Medicine Division, Stockholm, Sweden.
Anders BlombergUmeå University, Department of Public Health and Clinical Medicine, Umeå, Sweden.ORCID https://orcid.org/0000-0002-2452-7347

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcoidosis is an immune-mediated inflammatory disease whose natural development is not well understood. We aimed to determine if inflammatory plasma protein levels are elevated before sarcoidosis diagnosis compared to controls. Furthermore, we investigated which proteins are increased and how long before diagnosis they are increased.

methodsCases with sarcoidosis and controls matched 2:1 on sex, birthdate, subcohort and sample date were identified in the Northern Sweden Health and Disease Study to perform a nested case-control study. Cases were validated and included if they provided one or more plasma samples at least 2 years before sarcoidosis diagnosis. Plasma protein levels were measured using the Olink Inflammation panel and expressed in normalised protein expression values. Unconditional logistic regression models adjusted for age, sex, subcohort and time since sampling were used to estimate log odds ratios with 95% confidence intervals for each protein overall and by time to diagnosis. p-values were adjusted for multiple comparisons using the Benjamini-Hochberg method.

resultsWe included 152 cases and 341 controls. Mean time between sample and sarcoidosis diagnosis was 13.4 years. 44 proteins were significantly elevated prior to sarcoidosis compared to controls in multivariable-adjusted analyses. The 10 proteins with the lowest p-values were CCL-3, CCL-19, cub domain-containing protein 1, CXCL9, CXCL10, interferon-γ, interleukin-12B, monocyte chemoattractant protein-3, tumour necrosis factor (TNF), and TNF receptor superfamily 9. Fewer proteins were associated with sarcoidosis in samples taken longer before diagnosis. Restricting to samples taken ≥10 years prior to sarcoidosis diagnosis, 27 proteins remained statistically significant.

conclusionSeveral inflammatory proteins were elevated in plasma many years before sarcoidosis onset compared to controls, revealing a pre-clinical phase characterised by inflammation.

Indexed as

SarcoidosisAdultAgedBiomarkersBlood ProteinsCase-Control StudiesChemokine CXCL10Chemokine CXCL9FemaleHumansInflammationInterferon-gammaLogistic ModelsMaleMiddle AgedMultivariate AnalysisBiomarkersBlood ProteinsChemokine CXCL10Chemokine CXCL9Interferon-gammaTumor Necrosis Factor-alpha

Identifiers

PMID39326919
PMCPMC11684420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.